Skip to main content
. Author manuscript; available in PMC: 2019 Mar 6.
Published in final edited form as: Perspect ASHA Spec Interest Groups. 2018 Jan;3(12):99–112. doi: 10.1044/persp3.SIG12.99

Table 2.

Middle estimate of AE and related cost reduction for ICU and non-ICU patients who need AT or AAC.

Adverse Event Estimated Annual Reduction in Number of Cases Estimated Annual Cost Reduction (Millions of Dollars)
Pressure Ulcers ICU 55,771 948
Non-ICU 166,049 2,823
Total 221,820 3,771
Ventilator Associated Pneumonias ICU 1,888 40
Non-ICU N/A N/A
Total 1,888 40
Falls ICU 12,355 89
Non-ICU 36,786 266
Total 49,141 355
Adverse Drug Reactions ICU 69,156 346
Non-ICU 205,901 1,000
Total 275,057 1,346